230 related articles for article (PubMed ID: 21154235)
21. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
22. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.
Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H
J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459
[TBL] [Abstract][Full Text] [Related]
23. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
24. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
25. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
[TBL] [Abstract][Full Text] [Related]
27. Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling.
Gros A; Menguy S; Bobée V; Ducharme O; Cassaigne IC; Vergier B; Parrens M; Beylot-Barry M; Pham-Ledard A; Ruminy P; Jardin F; Merlio JP
PLoS One; 2022; 17(4):e0266978. PubMed ID: 35452489
[TBL] [Abstract][Full Text] [Related]
28. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
[TBL] [Abstract][Full Text] [Related]
29. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
[TBL] [Abstract][Full Text] [Related]
30. Skin Involvement of Mantle Cell Lymphoma May Mimic Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type.
Wehkamp U; Pott C; Unterhalt M; Koch K; Weichenthal M; Klapper W; Oschlies I
Am J Surg Pathol; 2015 Aug; 39(8):1093-101. PubMed ID: 26034867
[TBL] [Abstract][Full Text] [Related]
31. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling.
Hoefnagel JJ; Dijkman R; Basso K; Jansen PM; Hallermann C; Willemze R; Tensen CP; Vermeer MH
Blood; 2005 May; 105(9):3671-8. PubMed ID: 15308563
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID.
Dijkman R; Tensen CP; Buettner M; Niedobitek G; Willemze R; Vermeer MH
Blood; 2006 Jun; 107(12):4926-9. PubMed ID: 16507780
[TBL] [Abstract][Full Text] [Related]
33. Expression of FOXP1 and Colorectal Cancer Prognosis.
De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
35. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
36. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
37. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
38. Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform.
Robson A; Shukur Z; Ally M; Kluk J; Liu K; Pincus L; Sahni D; Sundram U; Subtil A; Karai L; Kempf W; Schieke S; Coates P
Histopathology; 2016 Jul; 69(1):11-9. PubMed ID: 26332336
[TBL] [Abstract][Full Text] [Related]
39. [Primary cutaneous diffuse large B-cell lymphoma, leg type: a study of clinicopathology, immunophenotype and gene rearrangement].
Wang T; Jia L; Liao W; Chen L; Chen X; Xiong Y; Hao F; Zhu X; Yang X; Wang L
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):100-5. PubMed ID: 25916640
[TBL] [Abstract][Full Text] [Related]
40. The significance of FOXP1 in diffuse large B-cell lymphoma.
Gascoyne DM; Banham AH
Leuk Lymphoma; 2017 May; 58(5):1037-1051. PubMed ID: 27678023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
